SGCE

sarcoglycan epsilon

Basic information

Region (hg38): 7:94524204-94656572

Previous symbols: [ "DYT11" ]

Links

ENSG00000127990NCBI:8910OMIM:604149HGNC:10808Uniprot:O43556AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myoclonic dystonia 11 (Strong), mode of inheritance: AD
  • myoclonus-dystonia syndrome (Supportive), mode of inheritance: AD
  • myoclonic dystonia 11 (Definitive), mode of inheritance: AD
  • myoclonic dystonia 11 (Strong), mode of inheritance: AD
  • myoclonic dystonia 11 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Dystonia 11, myoclonicADNeurologicTreatment with deep-brain stimulation may be beneficialMusculoskeletal; Neurologic4434166; 11528394; 12325078; 12391346; 11912106; 12634861; 12821748; 12743249; 16240355; 15728306; 17101905; 16534121; 16227522; 18362280; 20301587; 20800530; 21220679; 21267590; 21825253; 22026499

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SGCE gene.

  • Myoclonic_dystonia_11 (576 variants)
  • not_provided (151 variants)
  • Inborn_genetic_diseases (46 variants)
  • not_specified (21 variants)
  • SGCE-related_disorder (12 variants)
  • Myoclonus-dystonia_syndrome (2 variants)
  • Movement_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SGCE gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003919.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
94
clinvar
2
clinvar
101
missense
5
clinvar
7
clinvar
279
clinvar
10
clinvar
301
nonsense
28
clinvar
8
clinvar
3
clinvar
39
start loss
1
1
frameshift
67
clinvar
13
clinvar
1
clinvar
81
splice donor/acceptor (+/-2bp)
18
clinvar
10
clinvar
2
clinvar
30
Total 118 38 291 104 2

Highest pathogenic variant AF is 0.000081290826

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SGCEprotein_codingprotein_codingENST00000445866 1270980
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.02380.9761257070231257300.0000915
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.052072540.8140.00001333014
Missense in Polyphen6496.2820.664721165
Synonymous0.09828990.20.9870.00000480873
Loss of Function3.38826.90.2970.00000154302

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.0001500.000149
Middle Eastern0.000.00
South Asian0.00009800.0000980
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix.;
Disease
DISEASE: Dystonia 11, myoclonic (DYT11) [MIM:159900]: A myoclonic dystonia. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT11 is characterized by involuntary lightning jerks and dystonic movements and postures alleviated by alcohol. Inheritance is autosomal dominant. The age of onset, pattern of body involvement, presence of myoclonus and response to alcohol are all variable. {ECO:0000269|PubMed:11528394, ECO:0000269|PubMed:12402271, ECO:0000269|PubMed:15079037, ECO:0000269|PubMed:15258227, ECO:0000269|PubMed:16227522, ECO:0000269|PubMed:17853490, ECO:0000269|PubMed:18175340, ECO:0000269|PubMed:18362280, ECO:0000269|PubMed:19066193, ECO:0000269|PubMed:21796726}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.231

Intolerance Scores

loftool
0.0924
rvis_EVS
-0.54
rvis_percentile_EVS
20.54

Haploinsufficiency Scores

pHI
0.423
hipred
Y
hipred_score
0.758
ghis
0.578

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.558

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sgce
Phenotype
muscle phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
cell-matrix adhesion;muscle organ development
Cellular component
Golgi apparatus;cytoskeleton;plasma membrane;integral component of plasma membrane;dystrophin-associated glycoprotein complex;sarcoglycan complex;dendrite membrane;sarcolemma
Molecular function